Print Page   |   Contact Us   |   Sign In   |   Register
RTP Chpt- Industry Giants Team Up for Healthcare : GSK + Verily* => Galvani
Register Map this EventMap this Event Tell a Friend About This EventTell a Friend
 

Consulting group PwC recently released a paper titled Top Health Industry Issues of 2017: A Year of Uncertainty and Opportunity which discusses "adapting for value, innovating for value and building for value". A key trend in the 'build for value' category is new partnerships and collaborations. No better example of this concept in action locally in RTP is GlaxoSmithKline's partnership with Google parent Alphabet's Life Sciences division, Verily, to form Galvani Bioelectronics.

 Export to Your Calendar 9/19/2017
When: Tuesday, September 19, 2017
5:30 pm - 8:30 pm
Where: Map this event »
Mez Restaurant
5410 Page Road
Durham, North Carolina  27703
United States
Contact: Andrea Paré


Online registration is available until: 9/19/2017
« Go to Upcoming Event List  

To register for this face to face event, click on Register above.

Industry Giants Team Up for Healthcare : GSK + Verily* => Galvani
* Verily : an Alphabet Inc subsidiary formerly Google Life Sciences

Consulting group PwC recently released a paper titled Top Health Industry Issues of 2017: A Year of Uncertainty and Opportunity which discusses "adapting for value, innovating for value and building for value".  A key trend in the 'build for value' category is new partnerships and collaborations

No better example of this concept in action locally in RTP is GlaxoSmithKline's partnership with Google parent Alphabet's Life Sciences division, Verily, to form Galvani Bioelectronics. Galvani's mission is to research and develop systems that use electrical signals in the human body to offset diseases. Formed in August 2016, the company will invest over $700M in the next seven years to create miniaturized, implantable devices that can modify irregular or altered electrical nerve signals that occur in many chronic illnesses including type 2 diabetes, arthritis and asthma.

How do two giants in their respective industries partner to successfully produce these life-enhancing devices? What are the challenges and how have the companies addressed them? Come learn from Adam Roth, founding member of the Galvani joint venture and leader of its Business Development activities, as he shares progress and insights.

What Attendees Will Learn

  • Nature and scope of the GSK/Alphabet alliance
  • Given more simple options for collaboration available, why a joint venture chosen as the best path forward
  • Critical success factors for the partnership
  • How inherent cultural differences between biopharma and high tech are being addressed
  • Best practices and lessons learned that attendees may consider for their alliance situations

 

Adam Roth, Director and Head of Business Development & Operations, Galvani

Click here for bio

Agenda

5:30 pm - 6:15 pm

Registration and Networking

6:15 pm - 6:30 pm

Dinner Served

6:30 pm - 6:45 pm

RTP ASAP Chapter President's Remarks and

Speaker Introduction

6:45 pm - 7:45 pm

Galvani Presentation + Q/A

7:45 pm - 8:00 pm

Closing Remarks and Networking

 

Attendees will be entered into a drawing for 2 Tile Mates 

The ASAP RTP Chapter would like to thank ASAP corporate member GSK (GlaxoSmithKline) for hosting this event.


For more information email us at info@strategic-alliances.org or call +1-781-562-1630